A recent paper describes how increased CEP89 copy number and expression correlates with a worse prognosis in ovarian cancer [114], which we hypothesise could be linked to Cep89’s role in modulating G0 arrest. This evidence concerns the gene CEP89 and ovarian carcinoma.